| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
25,507,000 | 20,729,000 | 15,981,000 | 11,680,000 | 9,739,000 |
| Cost of Revenue
|
-12,350,000 | -10,739,000 | -8,814,000 | -6,647,000 | -5,002,000 |
|
Gross Profit
|
13,155,000 | 9,989,000 | 7,166,000 | 5,033,000 | 4,737,000 |
|
Operating Income/Expenses
|
-10,874,000 | -8,303,000 | -6,393,000 | -5,458,000 | -6,245,000 |
|
Total Operating Profit/Loss
|
2,281,000 | 1,686,000 | 773,000 | -425,000 | -1,508,000 |
| Total Net Finance Income/Expense
|
64,000 | 25,000 | -1,000 | 0 | -1,000 |
| Net Investment Income
|
-14,000 | 13,000 | 0 | -63,000 | -85,000 |
| Irregular Income/Expenses
|
-2,000 | 0 | -867,000 | -124,000 | -157,000 |
|
Other Income/Expense, Non-Operating
|
-41,000 | -80,000 | 21,000 | 9,000 | 17,000 |
|
Non-Operating Income/Expenses, Total
|
7,000 | -42,000 | -847,000 | -178,000 | -226,000 |
|
Pretax Income
|
2,288,000 | 1,644,000 | -71,000 | -602,000 | -1,735,000 |
| Provision for Income Tax
|
25,000 | 187,000 | 411,000 | -4,000 | 3,000 |
|
Net Income from Continuing Operations
|
2,313,000 | 1,831,000 | 340,000 | -606,000 | -1,732,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
2,313,000 | 1,831,000 | 340,000 | -606,000 | -1,732,000 |
|
Non-Controlling/Minority Interests
|
-34,000 | -- | -- | -- | -- |
|
Net Income after Non-Controlling/Minority Interests
|
2,274,000 | 1,826,000 | 340,000 | -606,000 | -1,732,000 |
|
Net Income Available to Common Stockholders
|
2,274,000 | 1,826,000 | 340,000 | -606,000 | -1,732,000 |
|
Diluted Net Income Available to Common Stockholders
|
2,274,000 | 1,826,000 | 340,000 | -606,000 | -1,732,000 |
| Basic EPS
|
19.76 | 15.87 | 2.94 | -5.31 | -15.46 |
| Diluted EPS
|
19.59 | 15.65 | 2.90 | -5.31 | -15.46 |
|
Basic Weighted Average Shares Outstanding
|
115,097.60 | 115,059.86 | 115,646.26 | 114,124.29 | 112,031.05 |
|
Diluted Weighted Average Shares Outstanding
|
115,869.02 | 116,677.32 | 117,241.38 | 114,124.29 | 112,031.05 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
2,212,000 | 1,619,000 | -70,000 | -602,000 | -1,735,000 |
|
EBITDA
|
2,248,000 | 1,681,000 | -40,000 | -600,000 | -1,686,000 |
|
Normalized EBITDA
|
2,576,000 | 2,003,000 | 1,047,000 | -340,000 | -1,404,000 |
|
Normalized Income
|
2,313,000 | 2,057,237.20 | 796,000 | -409,000 | -1,495,000 |
|
Total Unusual Items
|
0 | 322,000 | 1,087,000 | 260,000 | 282,000 |
|
Total Unusual Items Excluding Goodwill
|
0 | 322,000 | 1,087,000 | 260,000 | 282,000 |
|
Tax Effect of Unusual Items
|
0 | 95,762.80 | 252,184 | 60,320 | 487.58 |
12/31/2022 - 10/25/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade